戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 quires residues in the amino terminus of the Agouti protein.
2 yproline residues found in the middle of the agouti protein.
3 ses the effect of the endogenous antagonist, agouti protein.
4                                              Agouti protein, a paracrine signaling molecule normally
5 me, which results from ectopic expression of agouti protein, a pigmentation factor normally expressed
6 tions regarding the biochemical mechanism of Agouti protein action, and provide evidence of a novel s
7                         However, full-length Agouti protein acts by an additional mechanism that is t
8 , but mutations that cause overexpression of agouti protein, an antagonist of the receptor, result in
9                                              Agouti protein and Agouti-related protein (Agrp) are par
10                                              Agouti protein and Agouti-related protein (Agrp) regulat
11                                              Agouti protein and agouti-related protein are homologous
12 to the Mc1r, and that the similarity between Agouti protein and Agrp includes their binding sites.
13  binding by the carboxyl-terminal portion of Agouti protein and down-regulation of melanocortin recep
14                                              Agouti protein and the Agouti-related protein (AGRP) are
15               We find that carboxyl-terminal Agouti protein, and all forms of Agrp tested, act solely
16 rize pharmacologic properties of recombinant Agouti protein, and have directly measured its cell-surf
17  by Agrp, which indicates that alpha-MSH and Agouti protein bind in a mutually exclusive way to the M
18 hat attractin is a low-affinity receptor for agouti protein, but not Agrp, in vitro and in vivo.
19 gmentary effects of Agouti, and suggest that Agouti protein can act as an agonist of the Mc1r in a wa
20 ne-scanning mutagenesis was performed on the agouti protein carboxyl terminus to locate residues impo
21  that the electrophoretic mobility of native Agouti protein corresponds to the mature full-length for
22                             In melanophores, Agouti protein has no effect in the absence of alpha-MSH
23  and carboxyl-terminal fragments of Agrp and Agouti protein in a sensitive bioassay based on pigment
24 hat BMP signaling controls the expression of Agouti protein in the hair follicle and provide evidence
25  (FAS) gene expression; further, recombinant agouti protein increases in cultured adipocytes and thes
26 n dissociation constants for mouse and human agouti protein inhibition of ligand binding to the melan
27                                    The human agouti protein is 85% homologous to mouse agouti; howeve
28                                    The mouse agouti protein is a paracrine signaling molecule that ca
29                                          The Agouti protein is normally expressed in the skin and act
30                                Expression of Agouti protein is normally limited to the skin where it
31 pic hormone, melanocyte stimulating hormone, agouti protein ligands (in rodents), c-Kit, and the endo
32 sistant to the effects of agouti, suggesting agouti protein may not play a role in human pigmentary v
33 el signaling mechanism whereby alpha-MSH and Agouti protein or Agrp function as independent ligands t
34 ides based on the sequence of this loop from Agouti protein or human AGRP are functional antagonists
35 sibly influencing the biogenesis of secreted agouti protein or modulating protein-protein interaction
36 date for a receptor mediating the effects of agouti protein overexpression.
37                                          The agouti protein plays an important role in the developmen
38              A carboxyl-terminal fragment of Agouti protein, Ser73-Cys131, is sufficient for melanoco
39 an adipocytes, and we have shown recombinant agouti protein to increase adipocyte intracellular Ca2+(
40  homology to the corresponding region of the agouti protein, which is an MC1R antagonist involved in

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。